Free public records show Infinite Biomedical Technologies in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Infinite Biomedical Technologies or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
3 active studies led by Infinite Biomedical Technologies, of 7 in all
Source: ClinicalTrials.gov, Studies with Infinite Biomedical Technologies (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
3 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies Infinite Biomedical Technologies leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Infinite Biomedical Technologies or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Infinite Biomedical Technologies: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Infinite Biomedical Technologies is in.
Stories on the topics Infinite Biomedical Technologies works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Vitamin D is made in sunlight, yet low levels are common even in sunny countries. How much you need, and when…
ReadSearch all reports for Infinite Biomedical Technologies All companies